NewGenIvf Group Limited (NASDAQ:NIVF) Stock Short Interest Report for October

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 2,470,389 shares, an increase of 3,427.1% from the September 30th total of 70,041 shares. Currently, 325.1% of the shares of the company are sold short. Based on an average daily trading volume, of 33,175,029 shares, the short-interest ratio is currently 0.1 days.

NewGenIvf Group Price Performance

NASDAQ:NIVF traded down $0.30 during mid-day trading on Monday, hitting $1.16. The company’s stock had a trading volume of 279,455 shares, compared to its average volume of 411,040. NewGenIvf Group has a 1 year low of $1.14 and a 1 year high of $21,425.47. The business’s fifty day moving average is $23.82 and its two-hundred day moving average is $463.22.

NewGenIvf Group (NASDAQ:NIVF) last issued its quarterly earnings data on Wednesday, October 7th. The company reported ($426.24) EPS for the quarter, missing analysts’ consensus estimates of $581.76 by ($1,008.00). The firm had revenue of $0.96 million for the quarter, compared to analyst estimates of $20.10 million. Research analysts expect that NewGenIvf Group will post 1365.44 EPS for the current year.

Analysts Set New Price Targets

NIVF has been the topic of a number of research analyst reports. Wall Street Zen lowered shares of NewGenIvf Group to a “strong sell” rating in a report on Saturday. Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, July 24th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIvf Group Limited is a reproductive-healthcare company focused on fertility treatment and assisted reproductive technology. Through its operating businesses, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF) and related fertility-care procedures.

Its services may include fertility consultations, laboratory-based embryo procedures, intracytoplasmic sperm injection (ICSI), embryo transfer, fertility preservation, and genetic testing or screening associated with assisted reproduction.